Noida (Uttar Pradesh) [India], January 3 (ANI): Kumar Kundan, a journalist who volunteered for human trials of Bharat Biotech's Covid vaccine, refuted rumours about the side effects of "Covaxin" as the Drugs Controller General of India (DCGI) has finally given approval for the vaccine agains
Hyderabad (Telangana) [India], January 3 (ANI): Soon after Prime Minister Narendra Modi applauded the scientists for obtaining emergency use approval from Drugs Controller General of India (DCGI) for indigenous vaccines against COVID-19 on Sunday, the developer of Covaxin, Bharat Biotech,
New Delhi [India], January 3 (ANI): Hours after Drugs Controller General of India (DCGI) approved restricted use in an emergency situation to Bharat Biotech's COVID-19 vaccine, Indian Council of Medical Research (ICMR) on Sunday said data generated through pre-clinical studies and various ph
New Delhi [India], January 3 (ANI): As the COVID-19 vaccines of Serum Institue of India and Bharat Biotech have been granted permission for restricted use in an emergency situation, Union Health Minister Dr Harsh Vardhan on Sunday termed it as "watershed moment" in India's battle against COV
New Delhi [India], January 3 (ANI): Union Home Minister Amit Shah and Bharatiya Janata Party (BJP) chief JP Nadda on Sunday hailed the country's scientists and frontline workers after the Drugs Controller General of India (DCGI) approved the Serum Institue of India and Bharat Biotech's CO
New Delhi [India], January 3 (ANI): Coronavirus situation in the national capital is under control, Delhi Health Minister Satyendar Jain said on Sunday.
New Delhi [India], January 3 (ANI): With COVID-19 vaccines of Serum Institue of India and Bharat Biotech being granted permission for restricted use in an emergency situation, Union Minister of State for Health and Family Welfare Ashwini Kumar Choubey on Sunday stated that India will become
New Delhi [India], January 3 (ANI): Prime Minister Narendra Modi congratulated the country as Drugs Controller General of India (DCGI) granted emergency use approval to Serum Institute of India and Bharat Biotech for their COVID-19 vaccines on Sunday.
New Delhi [India], January 3 (ANI): COVID-19 vaccines of Serum Institue of India and Bharat Biotech have been granted permission for restricted use in emergency situation, said Drugs Controller General of India (DCGI) on Sunday.
New Delhi [India], January 2 (ANI): With an expert panel of Drugs Controller General of India (DCGI) recommending grant of restricted emergency use authorisation to Bharat Biotech's indigenously developed COVID-19 vaccine on Saturday, doctors said it was a good development as the vaccine i
Hyderabad (Telangana) [India], January 2 (ANI): Bharat Biotech has recruited 23,000 volunteers so far for the Phase III clinical trials of its COVID-19 vaccine candidate, 'COVAXIN'.
New Delhi [India], January 2 (ANI): The Subject Expert Committee (SEC) of Central Drugs Standards Control Organisation on Saturday made recommendations to the Drugs Controller General of India to grant permission for restricted emergency use of SII, Bharat Biotech's vaccines.